GLP-1 weight loss drugs could increase risk of osteoporosis and gout, new research finds Bookmark CommentsGo to comments Taking popular GLP-1 class weight loss drugs like Ozempic and Wegovy could be linked to a higher risk of developing osteoporosis, gout and a condition that causes severe bone softening compared to people who dont use the medications, researchers said Monday
Weight Loss: A Transformative Benefit For many patients with Type 2 diabetes, weight loss is as important as glucose control
"Ipamorelin, a new growth hormone-releasing peptide, is a potent stimulator of growth hormone release in humans." The Journal of Clinical Endocrinology & Metabolism, 85(4), 12771280
Acute sight-threatening emergencies: Acute angle-closure glaucoma, retinal detachment, central retinal artery occlusion, wet AMD with active bleeding
However, maintaining a healthy lifestyle is important to prevent the formation of new fat deposits
More clinical trials could result in the drugs being approved for more uses
